The effects of the association bindarit + irbesartan versus irbesartan alone on albuminuria of patients with Diabetic Nephropathy. Double-blind placebo-controlled study followed by an open extension phase.
The effects of the association bindarit irbesartan versus irbesartan alone on albuminuria of patients with Diabetic Nephropathy. Placebo-controlled study.
- Registry ID
- EUCTR2006-006191-38
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Angelini Farmaceutici, ACRAF S.p.A.
- Start date
- 2008-02-28
- Completion date
- 2008-12-02
- Last update
- 2026-08-16
Conditions
- Diabetic Nephropathy (Type 2 diabetes)
- Patients with type II diabetes with nephropathy
Summary
Primary objective of the study is to compare the reduction of UAE between treatment groups in patients with type 2 diabetes and micro- or macroalbuminuria.
Locations
View on source registry